Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathway activation patterns in diffuse large B-cell lymphomas.

S Bentink1, S Wessendorf, C Schwaenen

  • 1Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.

Leukemia
|June 27, 2008
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.

Leukemia·2026
Same author

Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept.

Leukemia·2025
Same author

Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target.

Nature communications·2025
Same author

Semen analysis and reproductive hormones in boys with classical Hodgkin lymphoma treated according to the EuroNet-PHL-C2 protocol.

Human reproduction (Oxford, England)·2024
Same author

The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone.

Human reproduction (Oxford, England)·2024
Same author

Prevention of activated brown adipose tissue on <sup>18</sup>F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trial.

Scientific reports·2023
Same journal

Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemia.

Leukemia·2026
Same journal

Selective targeting of RSK signaling with PMD-026 suppresses FLT3-activated acute myeloid leukemia while sparing normal hematopoiesis.

Leukemia·2026
Same journal

FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.

Leukemia·2026
Same journal

Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasms.

Leukemia·2026
Same journal

Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability.

Leukemia·2026
Same journal

Unpacking the epigenetic landscape of acute lymphoblastic leukemia: resolving cellular heterogeneity and nutritional complexities.

Leukemia·2026
See all related articles
This summary is machine-generated.

Machine learning identified pathway activation patterns (PAPs) in aggressive B-cell lymphomas. These patterns revealed four distinct patient groups with unique characteristics and prognoses, aiding personalized cancer treatment.

Area of Science:

  • Oncology
  • Bioinformatics
  • Cancer Biology

Background:

  • Cancer involves deregulation of cell growth and survival pathways.
  • Pathway activity varies even within the same cancer type.
  • Targeted therapies require understanding tumor-specific pathway activation.

Purpose of the Study:

  • To develop pathway activation signatures for cancer.
  • To classify mature aggressive B-cell lymphomas based on pathway activity.
  • To identify distinct patient subgroups for improved treatment strategies.

Main Methods:

  • Utilized semi-supervised machine learning to create pathway signatures.
  • Combined signatures into pathway activation patterns (PAPs).
  • Analyzed PAPs in well-characterized aggressive B-cell lymphoma cohorts.

Related Experiment Videos

Main Results:

  • Identified PAPs conserved across tissue types.
  • Discovered four distinct molecular subgroups within aggressive B-cell lymphomas, separate from Burkitt lymphoma.
  • These subgroups exhibited unique biological features, genetic aberrations, and prognoses.
  • Findings were validated in an independent dataset.

Conclusions:

  • Pathway activation patterns (PAPs) effectively stratify mature aggressive B-cell lymphomas.
  • This molecular subtyping offers insights into distinct disease biology.
  • PAPs have potential for guiding personalized cancer therapy decisions.